Home Solutions is a provider of home infusion therapy services located throughout the Northeastern and Mid-Atlantic regions. The company has 400 employees and was founded in 1996 by its current CEO, Todd Timbrook. Home Solutions is Joint Commission accredited and is based in Northfield, NJ (www.infusioncare.com).
“We have had an incredible partnership with Home Solutions over the past five years,” said Ethan Budin, a Senior Principal at Flexpoint. “Todd Timbrook and his team have driven strong growth in the business, increasing from three locations to nine through both organic growth and acquisitions, and increasing revenue nearly three-fold through the tenure of our investment.”
Cain Brothers, an investment banking firm that focuses exclusively on the health care industry, acted as financial adviser to Home Solutions in connection with the transaction. Cain Brothers has office in New York, Chicago and San Francisco (www.cainbrothers.com).
Flexpoint Ford seeks to invest from $10 to $100 million in companies operating in the healthcare and financial services sectors. Flexpoint Ford currently has $1 billion in capital under management. The firm is based in Chicago, IL with an additional office in New York, NY (www.flexpointford.com).
“We identified the home infusion pharmacy market as an area of interest several years before we made our investment in Home Solutions,” said Jonathan Oka, a Vice President at Flexpoint. “Our core strategy of networking in industry segments of interest to find outstanding management teams led us to the company, and to a successful investing partnership. We wish Todd and the rest of the Home Solutions team much success as they continue to grow the business.”
KRG specializes in acquiring and recapitalizing unique and profitable middle-market companies. Since inception, KRG has invested in 45 platform companies and has completed 130 add-on acquisitions for those platforms. Founded in 1996, KRG has over $4 billion of capital under management and is based in Denver, CO (www.krgcapital.com).
© 2012 PEPD • Private Equity’s Leading News Magazine • 10-16-12